Uni-Bio Science Group Limited 0690.HK Stock
Uni-Bio Science Group Limited Price Chart
Uni-Bio Science Group Limited 0690.HK Financial and Trading Overview
| Uni-Bio Science Group Limited stock price | 0.09 HKD |
| Previous Close | 0.06 HKD |
| Open | 0.05 HKD |
| Bid | 0.05 HKD x 0 |
| Ask | 0.05 HKD x 0 |
| Day's Range | 0.05 - 0.06 HKD |
| 52 Week Range | 0.04 - 0.1 HKD |
| Volume | 2.64M HKD |
| Avg. Volume | 2.14M HKD |
| Market Cap | 343.7M HKD |
| Beta (5Y Monthly) | -0.206963 |
| PE Ratio (TTM) | 5.4 |
| EPS (TTM) | 0.01 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 22, 2007 |
| 1y Target Est | N/A |
0690.HK Valuation Measures
| Enterprise Value | 270.61M HKD |
| Trailing P/E | 5.4 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.78057027 |
| Price/Book (mrq) | 1.7419356 |
| Enterprise Value/Revenue | 0.615 |
| Enterprise Value/EBITDA | 4.546 |
Trading Information
Uni-Bio Science Group Limited Stock Price History
| Beta (5Y Monthly) | -0.206963 |
| 52-Week Change | -12.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 HKD |
| 52 Week Low | 0.04 HKD |
| 50-Day Moving Average | 0.06 HKD |
| 200-Day Moving Average | 0.07 HKD |
0690.HK Share Statistics
| Avg. Volume (3 month) | 2.14M HKD |
| Avg. Daily Volume (10-Days) | 969K HKD |
| Shares Outstanding | 6.36B |
| Float | 2.1B |
| Short Ratio | N/A |
| % Held by Insiders | 52.66% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 8.74% |
| Operating Margin (ttm) | 10.72% |
| Gross Margin | 76.05% |
| EBITDA Margin | 13.52% |
Management Effectiveness
| Return on Assets (ttm) | 10.54% |
| Return on Equity (ttm) | 20.87% |
Income Statement
| Revenue (ttm) | 440.32M HKD |
| Revenue Per Share (ttm) | 0.07 HKD |
| Quarterly Revenue Growth (yoy) | 24.60% |
| Gross Profit (ttm) | 334.88M HKD |
| EBITDA | 59.53M HKD |
| Net Income Avi to Common (ttm) | 38.51M HKD |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 108.62M HKD |
| Total Cash Per Share (mrq) | 0.02 HKD |
| Total Debt (mrq) | 22.8M HKD |
| Total Debt/Equity (mrq) | 11.71 HKD |
| Current Ratio (mrq) | 2.22 |
| Book Value Per Share (mrq) | 0.031 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 48.66M HKD |
| Levered Free Cash Flow (ttm) | 25.8M HKD |
Profile of Uni-Bio Science Group Limited
| Country | Hong Kong |
| State | N/A |
| City | Sha Tin |
| Address | No. 20 Science Park East Avenue |
| ZIP | N/A |
| Phone | 852 3102 3232 |
| Website | https://www.uni-bioscience.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 370 |
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. It operates in Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Boshutai, a small molecule drug to treat diabetes. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agent for the treatment of Type 2 diabetes. The company was incorporated in 2001 and is headquartered in Sha Tin, Hong Kong.
Q&A For Uni-Bio Science Group Limited Stock
What is a current 0690.HK stock price?
Uni-Bio Science Group Limited 0690.HK stock price today per share is 0.09 HKD.
How to purchase Uni-Bio Science Group Limited stock?
You can buy 0690.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Uni-Bio Science Group Limited?
The stock symbol or ticker of Uni-Bio Science Group Limited is 0690.HK.
Which industry does the Uni-Bio Science Group Limited company belong to?
The Uni-Bio Science Group Limited industry is Biotechnology.
How many shares does Uni-Bio Science Group Limited have in circulation?
The max supply of Uni-Bio Science Group Limited shares is 6.16B.
What is Uni-Bio Science Group Limited Price to Earnings Ratio (PE Ratio)?
Uni-Bio Science Group Limited PE Ratio is 8.80000000 now.
What was Uni-Bio Science Group Limited earnings per share over the trailing 12 months (TTM)?
Uni-Bio Science Group Limited EPS is 0.01 HKD over the trailing 12 months.
Which sector does the Uni-Bio Science Group Limited company belong to?
The Uni-Bio Science Group Limited sector is Healthcare.